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ORIGINAL ARTICLE
A prospective audit of requests for CT Pulmonary 
Angiography (CTPA) in haemodynamically stable  
non-pregnant medical patients with suspected PE 
Joëlle Azzopardi, Gabriel Degiorgio, Julian Cassar, Paula Grech, Gabriel Borg, Kyra Bartolo,  
Brendan Caruana Montaldo    
INTRODUCTION 
Pulmonary embolism (PE) is a common and occasionally fatal disease, 
therefore investigation must be targeted and accurate. Unnecessary 
investigation presents an increased risk of harm to the patient. On 
occasion, CT Pulmonary Angiography (CTPA) is not requested 
according to established guidelines.  
AIM 
This study aimed to address the criteria by which CTPAs were being 
requested.  Approval was obtained from data protection and ethics 
committees. Anonymous data was collected from hospital software 
and patients' case notes between Aug-Sept 2017. 
METHODS 
106 patients were recruited. Hospital notes were examined for 
demographics, reason for presentation, documentation of pre-test 
probability (PTP) testing, arterial blood gases (ABGs), 
electrocardiogram (ECG), indication for CTPA, and any complications. 
Hospital software provided data on blood investigations including D-
dimer, CXR, time of CTPA order, and department ordering CTPA. 
RESULTS 
Dyspnoea, followed by a raised D-dimer, was the most common 
trigger for ordering CTPA (45.3%). A large majority (60.4%) of 
patients undergoing CTPA did not have ABGs taken. One fifth 
(21.7%) of CTPAs were positive. A PTP score was only documented in 
10.4% of patients and was equally divided between Wells and Geneva 
scores. The Wells score was retrospectively calculated, with only 
9.4% having a score >4 indicating likely PE. 1 patient had anaphylaxis 
to contrast and 5 developed contrast-induced nephropathy. 
CONCLUSIONS 
A basis for requesting a CTPA needs to be established, utilising the 
well-validated Wells Score, and D-dimer where indicated. A suspicion 
of PE should trigger a request for an ABG. CTPA is not without 
morbidity, and therefore should only be requested according to 
evidence-base. 
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INTRODUCTION 
Pulmonary embolism (PE) is a common and 
occasionally fatal disease, therefore 
investigation must be targeted and accurate. It 
can manifest in a variety of ways, ranging from 
no symptoms or seemingly innocuous ones, to 
sudden death. The gold standard for 
investigation of PE is CT Pulmonary Angiogram 
(CTPA), albeit this is not without its risks, 
namely radiation exposure, risk of contrast 
nephropathy and anaphylaxis. Hence, 
unnecessary investigation presents 
an increased risk of harm to the patient. On 
occasion, CTPAs are requested arbitrarily 
rather than according to 
established guidelines.   
A high clinical suspicion is required to diagnose 
PE. Furthermore, effective scoring systems 
and algorithms have been developed to help 
guide physicians along the most appropriate 
management path. Once recognised, PE 
remains a highly treatable condition. 
AIMS  
This study aimed to address the criteria by 
which CTPAs were being requested by medical 
or emergency doctors in a local hospital, and 
whether these were in accordance with the 
European Society of Cardiology (ESC) 
guidelines.1 The primary aim of the audit was 
to assess whether CTPAs were being ordered 
appropriately. Secondary aims included 
whether scoring systems to stratify risk of PE 
were being used (Geneva or Wells Scores), 
whether supplementary investigations such as 
electrocardiogram (ECG), chest x-ray (CXR), 
arterial blood gases (ABGs) and D-Dimer were 
being requested and to identify any CTPA-
related complications. 
METHODOLOGY 
Patient Population 
All patients admitted from the Emergency 
Department to the Medical Department who 
underwent CTPA, within a 5-week period 
(between August and September 2017), were 
recruited prospectively, bringing the total to 
106 subjects. 
Questionnaire Design 
An extensive literature review was carried out, 
so as to create a template by which data would 
be scrutinised. Criteria which should be met for 
every patient suspected of having PE were 
documented in a tick-the-box fashion. Pre-test 
probability testing was given its due 
importance in the questionnaire, as was the D-
dimer result. The performing department was 
clearly documented, together with 
demographic data on each patient.   
Data Collection 
Approval was obtained from the data 
protection and University of Malta Research 
Ethics Committee. Data was collected 
prospectively from hospital software and case 
notes. Case notes were examined for 
demographics, reason for presentation, 
patient assessment, documentation of pre-
test probability (PTP) testing, ABGs, ECG, 
indication for CTPA, any complications, and 
further management. Hospital software 
provided data on blood investigations 
including serum chemistries, troponin, D-dimer 
and pro-BNP; CXR; time of CTPA order; and 
department ordering CTPA.   
RESULTS 
Demographics 
106 patients were recruited, of which 60.4% 
were female. A good proportion were over 50 
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years of age (Figure 1). The mean age of the 
study population was 63.8 years, with a median 
age of 68 years. 
 
Figure 1 Percentage distribution of age 
 groups of subject population 
 
Presentation to Accident & Emergency (A+E) 
Dyspnoea was the most common reason for 
presentation to A+E, being present in almost 
half (49.1%) of patients (Figure 2). Other 
reasons for presentation to hospital included 
cough, lethargy, palpitations and lower limb 
swelling. 
 
Figure 2 Presenting symptoms of subjects 
 undergoing CTPA (>1 symptom 
 may have been  present) 
 
 
 
 
 
 
 
Performing department and overview of 
CTPA outcome 
The CTPA scans taken into consideration were 
all those requested from A+E or medical 
specialities. Figure 3 shows that the majority 
were requested by the A+E department. Just 
over a fifth (21.7%) of CTPAs were positive for 
PE. Analysis of CTPA results requested by the 
individual department revealed that just under 
a third (29.0%) of scans ordered from A+E were 
positive, while only over one tenth (11.4%) 
ordered from the medical wards were positive 
(Figure 4).  
 
Figure 3 Department requesting CTPA 
 
 
Figure 4 Proportion of CTPAs positive for 
 PE by requesting department 
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CTPA – date, timing and primary indication 
The majority of patients had 2 or more 
symptoms that raised the suspicion for PE. The 
most common primary indication for CTPA was 
tachypnoea or sudden onset dyspnoea, 
present in almost two thirds (62.3%) of 
patients. Raised D-dimer was the second most 
common indication for CTPA, present in just 
under half of patients (45.3%). In a third 
(33.0%) the primary indication was pleuritic 
chest pain while 19.8% of patients 
demonstrated oxygen desaturation. 
Haemoptysis was an indication in only 3.8% of 
patients. Other reasons for performing CTPA 
included tachycardia, syncope and new RBBB. 
Serum investigations  
Complete blood count was measured in all 
subjects, and renal function in 99%. D-Dimer 
was considered in only 59.4% of patients. The 
cut-off for a normal D-Dimer was taken to be 
500ng/mL. It was elevated in 42.9% of patients 
in whom it was checked, implying that a good 
majority of those undergoing CTPA had a 
normal D-Dimer. Furthermore, 43.5% of 
patients with confirmed PE did not have a D-
Dimer taken (Figure 5).  
 
Figure 5 Proportion of those undergoing 
CTPA having a raised D-dimer, normal D-dimer, 
or not having had a D-dimer taken.  
 
Of those subjects with an elevated D-Dimer, 
40.7% were found to have a PE on CTPA. A 
positive CTPA was reported in only 5.6% of 
subjects with a normal D-Dimer, applauding 
the sensitivity of D-Dimer. 
ABG analysis was found to be grossly 
underutilised in the study population, being 
drawn in only 39.6%. The majority (83.3%) 
were found to have resting hypoxaemia (PaO2 
<80mmHg). The correlation of hypoxic 
patients also having a confirmed PE was of 
76.9%. This is to be expected as PE tends to 
cause Type 1 Respiratory Failure. 
ECG 
The most frequently encountered ECG 
changes in patients with PE are tachycardia, 
non-specific ST and T waves changes, right 
heart strain and right bundle branch block 
(RBBB). 
Every patient in the study had an ECG taken 
during the in-patient stay, and this was normal 
in half of subjects (50.9%). Sinus tachycardia 
was the most common abnormality, present in 
21.7%, while a bundle branch block was 
evident in 7.5%. Other ECG changes included 
ST changes, atrial fibrillation and heart strain 
pattern. 
CXR  
Every subject recruited in the study underwent 
a chest x-ray. The large majority (70.8%) were 
normal, while a small proportion revealed 
consolidation (7.5%), pleural effusion (6.6%) or 
pulmonary venous congestion (5.7%). Other 
changes included lung metastases, pleural 
plaques and interstitial lung disease. 
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Scoring system 
The Wells 2-3 and Geneva4 scores are the two 
most widely accepted scoring systems for PE. 
The modified (2-tier) Wells Score was selected 
for this audit (Figure 6). A score was only 
documented in 10.4% of patients. Of these, 
the Wells score was documented in 54.5%, and 
the Geneva score in 45.5%. 
The data collectors retrospectively calculated 
a Wells Score on each individual in the study. 
The score was agreed upon by 2 data collectors 
separately. The majority of patients (34%) had 
a Wells score of zero (Table 1). 
 
Figure 6 Traditional vs Modified Wells Score 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
According to the ESC Guidelines1, a Wells Score 
of ≤4 implies that PE is unlikely and therefore 
a D-dimer should be taken. 90.6% of the study 
population had a Wells Score of ≤4. Of these, 
just under a quarter (22.6%) had a positive D-
dimer and therefore correctly underwent 
CTPA, with a pick-up rate for PE of 41.7%. In 
the sub-group where PE was unlikely (Wells ≤4) 
and a D-dimer of <500ng/ml which excludes 
PE, unfortunately all 36 patients nonetheless 
underwent CTPA, of which only 2 CTPAs were 
positive. Another third (34%) of patients in the 
‘unlikely PE’ subgroup did not have D-dimer 
levels checked. In the small proportion of 
patients (9.4%) where PE was likely (Wells 
Score >4), 40% had a positive CTPA (Figure 7). 
Outcome of CTPA  
More than a fifth (21.7%) of CTPA scans were 
positive for PE. A number of patients had more 
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than one embolus. The vast majority were 
segmental (52.2%) while a sub-segmental PE 
was present in 21.7%. In 30.4% a main artery 
was involved while in 47.8% it was the 
interlobar artery which contained thrombus. 
Bilateral PE was present in 8.7%. 
32.1% of the patient population were 
unnecessarily exposed to ionizing radiation 
from a CTPA which was not indicated 
according to the ESC guidelines, while another 
27.4% were possibly unnecessarily exposed, as 
the D-dimer was not checked. 
One patient suffered contrast-induced 
anaphylaxis as a major complication from 
CTPA. A deterioration in eGFR was noted in 5 
patients (4.7%). All-cause mortality was 10.4% 
during the study period. 
Table 1 Distribution of Wells score (as 
calculated by the investigators) 
 
 
Figure 7 Summary of results: risk for PE, based upon the Modified Wells Score, and subsequent    
 investigation with CTPA and/or D-dimer 
 
 
  
 
 
 
 
 
 
 
 
 
 
Wells Score Percentage of 
subjects 
0 34 
1 10.4 
1.5 20.8 
2.5 7.5 
3 13.2 
3.5 0.9 
4 3.8 
4.5 1.9 
5.5 2.8 
6 0.9 
6.5 0.9 
7 0.9 
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DISCUSSION 
PE can present in a number of ways, the most 
commonly reported symptoms in this audit 
being acute shortness of breath, and pleuritic 
chest pain. These two symptoms were the 
main documented reasons for ordering a CTPA 
in patients making up the subject population. 
Other conditions may present similarly to PE, 
and thus a high index of clinical suspicion is 
necessary. History-taking should be geared 
towards specific factors that increase 
thrombotic tendency, thus precipitating PE. 
These risk factors are incorporated into the 
Wells Score, a validated scoring system used to 
grade the probability of PE. These include 
symptoms of DVT, prior history of DVT and PE, 
recent immobilisation and presence of 
malignancy. Haemoptysis and tachycardia are 
also features that are associated with PE. If no 
alternative diagnosis better explains 
symptoms, this adds to the Wells Score and 
increases the probability of PE. Although the 
Wells and Geneva scores which are clearly 
delineated in the ESC Guidelines on Acute 
Pulmonary Embolism are referred to locally as 
a guide to stratify risk for PE and thus refer 
patients for CTPA accordingly, there was no 
established local guideline at time of data 
collection.   
A scoring system (Wells or Geneva) was only 
calculated in 10.4% of study patients prior to 
ordering a CTPA. When the Wells Score was 
calculated retrospectively, PE was ruled out in 
at least one third, yet these still underwent 
CTPA, placing a not insignificant burden on 
radiology time and costs, whilst also exposing 
patients to unnecessary risks. These include 
ionizing radiation, contrast nephropathy and 
anaphylaxis. 1 patient sustained contrast-
induced anaphylaxis following scanning while 
5 patients (4.7%) experienced a deterioration 
in their eGFR. 10.4% of patients passed away 
during the study period however further 
mortality data was not looked into. 
Arterial blood gas analysis is a recommended 
investigation in patients presenting with 
symptoms suggestive of pulmonary 
pathology. These were only taken in a minority 
(39.6%) of the study population. A sizeable 
proportion (43.5%) of patients with a positive 
CTPA did not have ABGs taken. Type 1 
Respiratory Failure was present in 76.9% of 
patients with PE in whom ABGs were taken. 
These findings are very relevant as ABG 
analysis is a convenient bedside test which 
allows a rapid reflection of the physiological 
status of a patient and is valuable in prioritising 
an acutely unwell patient. 
A D-Dimer assay is recommended in those 
patients in whom PE is unlikely, thus a 
Modified Wells Score of ≤4. It is a highly 
sensitive but non-specific test for PE. D-dimer 
was only checked in 62.5% of those in whom it 
was indicated, and ruled out PE in 34% of those 
with a low Wells Score (≤4). In only 2 patients 
was a positive CTPA (non-guideline request) 
associated with a negative D-dimer.  
A limitation to the study was the relatively 
short period of recruitment. However, in this 
short period, it already became clear that 
guidelines were not being adhered to, with 
unnecessary risks to the patient and uncalled 
for costs to the hospital system. Furthermore, 
the Modified Wells Score was calculated 
retrospectively by the investigators, as PTP 
testing was only done in a minority of patients, 
and its absence would have precluded further 
evaluation. This may have been inaccurate by 
either under- or over-estimating the Wells 
score, since it was obtained from the patient’s 
case notes rather than from first-hand history-
taking and physical examination. Lastly D-
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dimer values were taken at face value rather 
than adjusting for age5. Thus, the number of 
CTPAs correctly requested may have been 
even lower. 
CONCLUSIONS 
A basis for requesting a CTPA needs to be 
established, utilising the well-validated Wells 
Score1, and D-dimer where indicated. A 
suspicion of PE should trigger a request for an 
arterial blood gas (ABG). CTPA is not without 
morbidity, and therefore should only be 
requested according to evidence-base. In the 
light of this audit’s overwhelming evidence 
that CTPAs are often requested without 
adherence to guidelines, there is currently 
liaison with the IT department to render a Well 
score compulsory, as well as a D-dimer level if 
indicated, when digitally requesting a CTPA. 
The authors, together with major stake 
holders, agree that employment of such 
measures when ordering CTPAs should 
decrease unnecessary requests, hence 
diminishing risks to patients, such as contrast-
induced nephropathy, anaphylaxis and 
radiation exposure, as well as limiting health-
care costs. 
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